These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32801747)

  • 1. Baicalin Attenuates YAP Activity to Suppress Ovarian Cancer Stemness.
    Li Y; Wang D; Liu J; Li Y; Chen D; Zhou L; Lang T; Zhou Q
    Onco Targets Ther; 2020; 13():7151-7163. PubMed ID: 32801747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis.
    Li Y; Hu Y; Yang L; Liu J; Cui C; Yang M; Zou D; Zhou L; Zhou Q; Ge W; Lang T
    Biomed Pharmacother; 2023 Apr; 160():114350. PubMed ID: 36804120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1.
    Tian C; Lang T; Qiu J; Han K; Zhou L; Min D; Zhang Z; Qi D
    Cancer Cell Int; 2020 Dec; 20(1):579. PubMed ID: 33292299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway.
    Gu J; Zhang Z; Lang T; Ma X; Yang L; Xu J; Tian C; Han K; Qiu J
    Onco Targets Ther; 2019; 12():8095-8104. PubMed ID: 31632062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
    Wu X; Wang Y; Zhong W; Cheng H; Tian Z
    Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway.
    Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T
    Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalin Antagonizes Prostate Cancer Stemness via Inhibiting Notch1/NF-κB Signaling Pathway.
    Wu MH; Wu K; Zhu YB; Li DC; Yang H; Zeng H
    Chin J Integr Med; 2023 Oct; 29(10):914-923. PubMed ID: 37357241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].
    Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibiting EMT, stemness and cell cycle involved in baicalin-induced growth inhibition and apoptosis in colorectal cancer cells.
    Yang B; Bai H; Sa Y; Zhu P; Liu P
    J Cancer; 2020; 11(8):2303-2317. PubMed ID: 32127957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EIF5A2 enhances stemness of epithelial ovarian cancer cells via a E2F1/KLF4 axis.
    Wang K; Wang Y; Wang Y; Liu S; Wang C; Zhang S; Zhang T; Yang X
    Stem Cell Res Ther; 2021 Mar; 12(1):186. PubMed ID: 33726845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
    Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
    J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFATC2 is a novel therapeutic target for colorectal cancer stem cells.
    Lang T; Ding X; Kong L; Zhou X; Zhang Z; Ju H; Ding S
    Onco Targets Ther; 2018; 11():6911-6924. PubMed ID: 30410349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASSF6 Is Downregulated In Human Bladder Cancers And Regulates Doxorubicin Sensitivity And Mitochondrial Membrane Potential Via The Hippo Signaling Pathway.
    Tan S; Bian X; Wu B; Chen X
    Onco Targets Ther; 2019; 12():9189-9200. PubMed ID: 31807003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.
    Zhang H; Lang TY; Zou DL; Zhou L; Lou M; Liu JS; Li YZ; Ding DY; Li YC; Zhang N; Zheng XD; Zeng XH; Zhou Q; Li L
    Onco Targets Ther; 2019; 12():11691-11700. PubMed ID: 32021247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc finger and SCAN domain containing 1, ZSCAN1, is a novel stemness-related tumor suppressor and transcriptional repressor in breast cancer targeting TAZ.
    Chu J; Li Y; He M; Zhang H; Yang L; Yang M; Liu J; Cui C; Hong L; Hu X; Zhou L; Li T; Li C; Fan H; Jiang G; Lang T
    Front Oncol; 2023; 13():1041688. PubMed ID: 36923432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.
    Gao F; Yu X; Meng R; Wang J; Jia L
    Onco Targets Ther; 2018; 11():5371-5381. PubMed ID: 30214243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
    Wang X; Zhang Y; Zhang S; Duan L
    Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of baicalin and baicalein on ovarian cancer cells.
    Chen J; Li Z; Chen AY; Ye X; Luo H; Rankin GO; Chen YC
    Int J Mol Sci; 2013 Mar; 14(3):6012-25. PubMed ID: 23502466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood exosome marker miRNA-30d-5p: Role and regulation mechanism in cell stemness and gemcitabine resistance of hepatocellular carcinoma.
    Tang B; Xie L; Tang X; Tian J; Xiao S
    Mol Cell Probes; 2023 Oct; 71():101924. PubMed ID: 37536457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRP1 Induces Enhanced Stemness and Chemoresistance in Glioma Cells via YAP.
    Jin L; Jin A; Wang L; Qi X; Jin Y; Zhang C; Niu M
    Biol Pharm Bull; 2024; 47(1):166-174. PubMed ID: 38220212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.